22.04.2014 Views

Abstracts (PDF file, 1.8MB) - Society for Risk Analysis

Abstracts (PDF file, 1.8MB) - Society for Risk Analysis

Abstracts (PDF file, 1.8MB) - Society for Risk Analysis

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

SRA 2013 Annual Meeting <strong>Abstracts</strong><br />

W3-B.4 Clewell, III, HJ*; Andersen, M; Gentry, PR; The<br />

Hamner Institutes <strong>for</strong> Health Sciences, ENVIRON International<br />

Corporation; hclewell@thehamner.org<br />

Pharmacokinetics of <strong>for</strong>maldehyde and the impact of<br />

endogenous levels on uptake<br />

Formaldehyde is present endogenously, with measurable<br />

concentrations in the tissues and exhaled breath of humans.<br />

While <strong>for</strong>maldehyde is highly water soluble and readily<br />

absorbed in the respiratory tract, there is little evidence of<br />

systemic delivery. The presence of endogenous concentrations<br />

of <strong>for</strong>maldehyde adds complexity to understanding the<br />

contribution of exogenous exposure to target tissue<br />

concentrations that may result in adverse effects.<br />

Computational Fluid Dynamic (CFD) modeling has been<br />

conducted to investigate the impact of the presence of<br />

endogenous <strong>for</strong>maldehyde on the absorption of exogenous<br />

<strong>for</strong>maldehyde from the nasal cavity of rats, monkeys, and<br />

humans. Based on the CFD modeling, exogenous exposure to<br />

concentrations below 0.2 ppm via inhalation are not expected to<br />

cause increases in tissue concentrations above background,<br />

even at the site of contact. At high exposure concentrations,<br />

<strong>for</strong>maldehyde concentrations are much greater in the air than<br />

in the tissue, which leads to rapid absorption in the anterior<br />

nasal passages due to the high rate of <strong>for</strong>maldehyde<br />

partitioning into nasal tissues. At low exposure concentrations,<br />

however, the concentration gradient between air and tissue is<br />

greatly reduced due to the presence of endogenous<br />

<strong>for</strong>maldehyde in nasal tissues, leading to reduced tissue dose.<br />

Biologically-based dose-response models have previously been<br />

developed to characterize both the toxicokinetics and<br />

toxicodynamics of <strong>for</strong>maldehyde in the rat and human;<br />

however, these models do not consider endogenous production<br />

of <strong>for</strong>maldehyde and thus the results at low concentrations may<br />

be questionable. Newer PK models can now track cellular<br />

<strong>for</strong>maldehyde and differential <strong>for</strong>mation of DNA-adducts from<br />

both endogenous and exogenous <strong>for</strong>maldehyde. These results<br />

suggest that understanding endogenous concentrations of a<br />

compound such as <strong>for</strong>maldehyde are of critical importance in<br />

characterizing the shape of the dose response curve in the low<br />

dose region <strong>for</strong> risk assessment.<br />

W4-J.1 Coglianese, C; University of Pennsylvania;<br />

cary_coglianese@law.upenn.edu<br />

Moving Forward in Looking Back: How to Improve<br />

Retrospective Regulatory Review<br />

Since 1982, the U.S. federal government has implemented an<br />

extensive regulatory review process that considers the costs<br />

and benefits of proposed regulations -- be<strong>for</strong>e they are adopted.<br />

By contrast, the federal government has little by way of<br />

institutionalized review of regulations' costs and benefits after<br />

they have been adopted. The Obama Administration -- like<br />

several earlier administrations -- has adopted an ad hoc<br />

retrospective review of existing regulations, or what it calls<br />

"regulatory look-back." This paper assesses the Obama<br />

regulatory look-back initiative, e.g., what it has undertaken and<br />

accomplished, but also analyzes additional steps that could be<br />

taken to improve, and even institutionalize, the practice of<br />

retrospectively evaluating existing risk regulations.<br />

T3-J.1 Coglianese, C*; Carrigan, C; University of Pennsylvania;<br />

cary_coglianese@law.upenn.edu<br />

Why Politicians Think Regulation Kills Jobs...When<br />

Economists Don't<br />

This paper juxtaposes the intense political controversy over the<br />

connection between jobs and regulation with the rather benign<br />

findings of the economics literature. For many politicians,<br />

regulations are "job-killers," while most of the economic<br />

research suggests that regulation yields no substantial net<br />

change in employment. This paper analyzes and explains the<br />

disjunction, showing that politicians respond to the distribution<br />

of job impacts while economists consider aggregate effects.<br />

While <strong>for</strong> many years, the impact analyses that accompanied<br />

new regulatory proposals contained little attention to<br />

employment effects, this has been because the economists' view<br />

prevailed. Since the 2008 recession, however, the political<br />

process has demanded more explicit focus on job impacts. This<br />

paper considers the rationale <strong>for</strong> job impact analysis of new risk<br />

regulations from the standpoint of democratic theory.<br />

T1-B.2 Cogliano, V; US Government; cogliano.vincent@epa.gov<br />

Enhancing IRIS: Progress to Date and Future Actions<br />

EPA has made numerous enhancements to its Integrated <strong>Risk</strong><br />

In<strong>for</strong>mation System (IRIS) program, which evaluates scientific<br />

in<strong>for</strong>mation on health effects that may result from exposure to<br />

environmental contaminants. These enhancements are intended<br />

(1) to improve the fundamental science of IRIS assessments, (2)<br />

to improve the productivity of the program, and (3) to increase<br />

transparency so issues are identified and debated early. The<br />

IRIS program has also enacted measures to ensure that the<br />

assessments it undertakes will be important to public health<br />

and to EPA’s priorities. As part of improving the fundamental<br />

science of IRIS assessments, the IRIS program is adopting<br />

principles of systematic review in all its new assessments. An<br />

expanded section on hazard identification will identify all health<br />

hazards where there is credible evidence of an effect.<br />

Assessments will include toxicity values <strong>for</strong> multiple health<br />

effects, increasing their utility in subsequent risk analyses and<br />

decisions. Be<strong>for</strong>e work on an assessment begins, conversations<br />

with EPA’s program and regional offices will ensure that IRIS<br />

assessments meet their varied needs, and input from external<br />

stakeholders will help in <strong>for</strong>mulating the problems to be<br />

addressed in the assessment. Improved science, improved<br />

productivity, and improved transparency – these will be evident<br />

in the new, enhanced IRIS program. The views expressed in<br />

this abstract do not necessarily represent the views or policies<br />

of the U.S. Environmental Protection Agency.<br />

December 8-11, 2013 - Baltimore, MD

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!